Dr. Charles W. Drescher

powered by
COS Expertise®
Pacific Gynecology Specialists
Swedish Medical Center
Gynecologic Oncology
Canary Foundation
Scientific Advisory Board
MemberAppointed: 2006
University of Washington
School of Medicine
Obstetrics and Gynecology
Clinical ProfessorAppointed: 1998
Fred Hutchinson Cancer Research Center
Public Health Sciences
Molecular Diagnostics Program
Joint Member
Professional Headshot of Charles W. Drescher

Mailing Address

Seattle, Washington 98109
United States

Contact Information

cdresche@fhcrc.org

Qualifications

M.D., University of Michigan, Medicine, 1982.

Expertise and Research Interests

Dr. Drescher is a partner and gynecologic surgeon at Pacific Gynecology Specialists located on the Swedish Medical Center campus in Seattle, Washington. His primary academic appointments are with the University of Washington as a Clinical Professor in the Department of Obstetrics and Gynecology with a joint appointment to the Translational and Outcomes Research Group in the Molecular Diagnostics Program at the Fred Hutchinson Center as an Associate Member. Dr. Drescher earned his Medical Degree in Medicine at the University of Michigan in Ann Arbor, where he also completed a residency in Obstetrics and Gynecology and a fellowship in Gynecologic Oncology.

Dr. Drescher is a co-Principal Investigator of a Specialized Program of Research Excellence (SPORE) in Ovarian Cancer grant funded by the National Cancer Institute where he oversees the recruitment and enrollment of ovarian cancer patients into a surgical (tissue) donation program. Dr. Drescher has extensive experience in collecting and processing tissues and blood specimens from patients, which are banked in the SPORE's Specimen Repository for use in research studies. In addition, he co-leads a SPORE project focused on molecular targets for ovarian cancer prognosis and therapy. As an expert in gynecological oncology, Dr. Drescher is actively involved in many ovarian cancer research organizations including on the Cancer Prevention committee of the Gynecological Oncology Group (GOG) and the Executive Committees of the Puget Sound Oncology Consortium and Pacific Ovarian Cancer Research Consortium. He is the former Medical Director of the Marsha Rivkin Center for Ovarian Cancer Research.

Keywords

COS Keywords:

Obstetrics Or Gynecology, Oncology, Outcomes Research (Medical), Ovarian Cancer, Surgery.

Additional Terms:

Gynecologic Surgery, Ovarian Cancer.

Memberships

American Medical Association
Gynecologic Cancer Foundation
King County Medical Society
Seattle Gynecological Society
Society of Gynecologic Oncologists
Washington State Medical Association

Previous Positions

1996-2005, Medical Director, Marsha Rivkin Center for Ovarian Cancer Research
1991-1998, Clinical Assistant Professor, University of Washington, School of Medicine, Obstetrics and Gynecology
1987-1989, Instructor, University of Michigan, Gynecological Oncology, Medical Center
1986-1987, Guest Lecturer and Surgeon, Komfo Anokye Teaching Hospital

Funding Received

  • Canary Foundation: Development of a Blood-Based Assay for the Early Detection of Ovarian Cancer, , 2005 to 2010.
  • National Institutes of Health (NIH): Modeling ovarian cancer screening for CEA, , 2002 to 2006.
  • National Institutes of Health (NIH): Pacific Ovarian Cancer Research Consortium: SPORE in Ovarian Cancer, , 1999 to 2009.

Publications

  • Lutz AM, Ray P, Willmann JK, Drescher C, Gambhir SS (Sept-Oct 2007) 2-deoxy-2-[F-18]fluoro-D-glucose accumulation in ovarian carcinoma cell lines., Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 9 (5), 260-6 Abstract
  • Andersen MR, Drescher CW, Zheng Y, Bowen DJ, Wilson S, Young A, McIntosh M, Mahony BS, Lowe KA, Urban N (Sep 2007) Changes in cancer worry associated with participation in ovarian cancer screening., Psycho-oncology, 16 (9), 814-20 Abstract
  • McIntosh MW, Liu Y, Drescher C, Urban N, Diamandis EP (Aug 2007) Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma., Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (15 Pt 1), 4422-8 Abstract
  • Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, Patras J, Mahony BS, Andersen MR (Jan 2007) Development of an ovarian cancer symptom index: possibilities for earlier detection., Cancer, 109 (2), 221-7 Abstract
  • Shah C, Pizer E, Veljovich DS, Drescher CW, Peters WA, Paley PJ (Dec 2006) Clear cell adenocarcinoma of the vagina in a patient with vaginal endometriosis., Gynecologic oncology, 103 (3), 1130-2 Abstract
  • Scholler N, Crawford M, Sato A, Drescher CW, O'Briant KC, Kiviat N, Anderson GL, Urban N (Apr 2006) Bead-based ELISA for validation of ovarian cancer early detection markers., Clinical cancer research : an official journal of the American Association for Cancer Research, 12 (7 Pt 1), 2117-24 Abstract
  • Stewart JJ, White JT, Yan X, Collins S, Drescher CW, Urban ND, Hood L, Lin B (Mar 2006) Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels., Molecular & cellular proteomics : MCP, 5 (3), 433-43 Abstract
  • Goodell V, Salazar LG, Urban N, Drescher CW, Gray H, Swensen RE, McIntosh MW, Disis ML (Feb 2006) Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 (5), 762-8 Abstract
  • Tu SP, Chen H, Chen A, Lim J, May S, Drescher C (Dec 2005) Clinical trials: understanding and perceptions of female Chinese-American cancer patients., Cancer, 104 (12 Suppl), 2999-3005 Abstract
  • McIntosh MW, Drescher C, Karlan B, Scholler N, Urban N, Hellstrom KE, Hellstrom I (Oct 2004) Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma., Gynecologic oncology, 95 (1), 9-15 Abstract
  • Andersen MR, Nelson J, Peacock S, Giedzinska A, Dresher C, Bowen D, Urban N (Aug 2004) Worry about ovarian cancer risk and use of screening by high-risk women: how you recruit affects what you find., American journal of medical genetics. Part A, 129 (2), 130-5 Abstract
  • Drescher CW, Nelson J, Peacock S, Andersen MR, McIntosh MW, Urban N (Apr 2004) Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening., Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 13 (4), 600-6 Abstract
  • Hellström I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellström KE (Jul 2003) The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma., Cancer research, 63 (13), 3695-700 Abstract
  • Horowitz NS, Powell MA, Drescher CW, Smith MR, Atwood M, Mate TA, Peters WA (Mar 2003) Adequate staging for uterine cancer can be performed through Pfannenstiel incisions., Gynecologic oncology, 88 (3), 404-10 Abstract
  • Brown JV, Peters WA, Rettenmaier MA, Graham CL, Smith MR, Drescher CW, Micha JP (Feb 2003) Three-consecutive-day topotecan is an active regimen for recurrent epithelial ovarian cancer., Gynecologic oncology, 88 (2), 136-40 Abstract
  • Andersen MR, Peacock S, Nelson J, Wilson S, McIntosh M, Drescher C, Urban N (Apr 2002) Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer., Gynecologic oncology, 85 (1), 3-8 Abstract
  • Horowitz NS, Peters WA, Smith MR, Drescher CW, Atwood M, Mate TP (Feb 2002) Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma., Obstetrics and gynecology, 99 (2), 235-40 Abstract
  • Peters WA, Smith MR, Drescher CW (Jun 2001) Rectal prolapse in women with other defects of pelvic floor support., American journal of obstetrics and gynecology, 184 (7), 1488-94; discussion Abstract
  • Brown JV, Peters WA, Rettenmaier MA, Karlan BY, Dillman RA, Smith MR, Drescher CW, Micha JP (Dec 2000) A phase I trial of a 3-day topotecan Q 21 days for recurrent epithelial cancers of the ovary, fallopian tube, and peritoneum., Gynecologic oncology, 79 (3), 495-8 Abstract
  • Drescher C, Holt SK, Andersen MR, Anderson G, Urban N (Jul 2000) Reported ovarian cancer screening among a population-based sample in Washington state., Obstetrics and gynecology, 96 (1), 70-4 Abstract
  • Cohn DE, Peters WA, Muntz HG, Wu R, Greer BE, Tamimi HK, Drescher CW, Smith MR, Yon JL, Schmidt R, Goff BA (Jun 1998) Adenocarcinoma of the uterine cervix metastatic to lymph nodes., American journal of obstetrics and gynecology, 178 (6), 1131-7 Abstract
  • Swisher E, Drescher CW (Jan 1998) Metastatic placental site trophoblastic tumor: long-term remission in a patient treated with EMA/CO chemotherapy., Gynecologic oncology, 68 (1), 62-5 Abstract
  • Urban N, Drescher C, Etzioni R, Colby C (Jun 1997) Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening., Controlled clinical trials, 18 (3), 251-70 Abstract
  • Smith MR, Peters WA, Drescher CW (Jun 1994) Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma., American journal of obstetrics and gynecology, 170 (6), 1677-81; discussion Abstract
  • Reid GC, Roberts JA, Hopkins MP, Schoeppel SL, Perez-Tamayo C, Drescher C, Chamberlain D, Morley GW (Jun 1993) Primary treatment of stage III ovarian carcinoma with sequential chemotherapy and whole abdominal radiation therapy., Gynecologic oncology, 49 (3), 333-8 Abstract
  • Drescher CW, Flint A, Hopkins MP, Roberts JA (Feb 1993) Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors., Gynecologic oncology, 48 (2), 242-6 Abstract
  • VanDevanter DR, Yirdaw G, Do C, Tysseling KA, Drescher CA, Forseth BJ, Von Hoff DD, McNutt MA (Dec 1992) Preparation of uniform, intact DNA samples from resected tumor tissues for pulsed-field gel electrophoretic analyses., BioTechniques, 13 (6), 884-7 Abstract
  • Hopkins MP, Drescher CW, McQuillan A, Keyser J, Schmidt R (Nov 1992) Malignant placental site trophoblastic tumor associated with placental abruption, fetal distress, and elevated CA-125., Gynecologic oncology, 47 (2), 267-71 Abstract
  • Drescher CW, Reid GC, Terada K, Roberts JA, Hopkins MP, Perez-Tamayo C, Schoeppel SL (Mar 1992) Continuous infusion of low-dose 5-fluorouracil and radiation therapy for poor-prognosis squamous cell carcinoma of the uterine cervix., Gynecologic oncology, 44 (3), 227-30 Abstract
  • Drescher CW, Hopkins MP, Roberts JA (Jun 1989) Comparison of the pattern of metastatic spread of squamous cell cancer and adenocarcinoma of the uterine cervix., Gynecologic oncology, 33 (3), 340-3 Abstract
  • Drescher C, Elkins TE, Adkeo O, Akins-Bekoe P, Agbemadzo T, Foster RL, Martey JO (Dec 1988) The incidence of urogenital Chlamydia trachomatis infections among patients in Kumasi, Ghana., International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 27 (3), 381-3 Abstract
  • Elkins TE, Drescher C, Martey JO, Fort D (Sep 1988) Vesicovaginal fistula revisited., Obstetrics and gynecology, 72 (3 Pt 1), 307-12 Abstract
  • Hopkins MP, Drescher CW, Morley GW (Sep 1987) Claudication as a rare symptom of recurrent cervical carcinoma., The American surgeon, 53 (9), 532-3 Abstract
  • Drescher CW, Peters WA, Roberts JA (Sep 1983) Contribution of endocervical curettage in evaluating abnormal cervical cytology., Obstetrics and gynecology, 62 (3), 343-7 Abstract

Profile Details

Last Verified: 4/17/2008

COS Expertise ID #1244728
Reference this profile directly: http://myprofile.cos.com/cwdrescher